MedTrace Logo

Equivalence Study of Specificity of PPD

NCT01798095 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 152

Last updated 2013-02-25

No results posted yet for this study

Summary

Determine if investigational products and reference standard produce similar responses.

Conditions

  • Tuberculosis Infection

Interventions

BIOLOGICAL

Aplisol@ PPD material

Determine equivalency of materials

BIOLOGICAL

Reference Standard

Reference standard material for comparison to newly produced materials.

Sponsors & Collaborators

  • Syneos Health

    collaborator OTHER

  • JHP Pharmaceuticals LLC

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2013-05-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01798095 on ClinicalTrials.gov